["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Wallén
Håkan
H
Danderyds sjukhus AB. h.n.wallen@telia.com
Agren
Anna
A
Nekludov
Michael
M
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002543:Cerebral Hemorrhage / Q000139:chemically induced; D000077144:Clopidogrel; D003511:Cyclohexanols / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D017809:Fatal Outcome; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D012307:Risk Factors; D015607:Stents; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069470:Venlafaxine Hydrochloride; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
D000925:Anticoagulants; D003511:Cyclohexanols; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D000069470:Venlafaxine Hydrochloride; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin